Serina Therapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation AL
Business Address 601 GENOME WAY, HUNTSVILLE, AL, 35806
Mailing Address 601 GENOME WAY, HUNTSVILLE, AL, 35806
Phone (256) 327-9630
Fiscal Year End 1231
EIN 821436829
Financial Overview
FY2024
$6.22M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
Material Events
8-K Financial Distress January 15, 2026
High Impact
- Opportunity to submit a detailed plan by February 8, 2026, to regain compliance with NYSE American listing standards.
- Potential for an 18-month 'Cure Period' until July 9, 2027, if the recovery plan is accepted, allowing continued trading.
8-K Other December 10, 2025
High Impact
- Serina Therapeutics submitted a complete response to the FDA regarding a clinical hold on its lead drug program, SER-252, for advanced Parkinson's disease.
- The clinical hold, issued by the FDA, had paused human trials due to serious questions or concerns, likely about safety or trial design.
Insider Trading
SELL 1 insiders
20 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.